Felix Karim

Felix Karim, PhD, is an accomplished executive in the biopharmaceutical industry with extensive experience in business development and research. Currently serving as Chief Business Officer for IDBiologics, Inc., Felix previously held key positions including Executive Vice President of Business Development at Blade Therapeutics, Vice President of Corporate and Business Development at Compugen Ltd., and Managing Director at FDK Consulting. Significant roles at Amgen, KAI Pharmaceuticals, Celera Genomics, and Exelixis highlight a robust career in strategic development and scientific advancement. Felix holds a Bachelor's degree from the University of California, Berkeley, and a PhD in Human Genetics from the University of Utah.